Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.565
-0.045 (-2.80%)
Mar 31, 2025, 1:41 PM EDT - Market open

BDTX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Selling, General & Admin
24.5227.1128.3930.0421.36
Upgrade
Research & Development
51.3159.3564.4496.8348.21
Upgrade
Operating Expenses
75.8486.4692.83126.8769.57
Upgrade
Operating Income
-75.84-86.46-92.83-126.87-69.57
Upgrade
Interest Expense
-----0
Upgrade
Interest & Investment Income
2.181.922.033.464.04
Upgrade
Earnings From Equity Investments
---2.25--
Upgrade
Currency Exchange Gain (Loss)
----00
Upgrade
Other Non Operating Income (Expenses)
3.140.920.18--
Upgrade
EBT Excluding Unusual Items
-70.51-83.62-92.87-123.41-65.53
Upgrade
Merger & Restructuring Charges
-2.95----
Upgrade
Gain (Loss) on Sale of Investments
3.781.17-0.54-2.19-1.73
Upgrade
Gain (Loss) on Sale of Assets
--2.23--
Upgrade
Pretax Income
-69.68-82.44-91.17-125.6-67.25
Upgrade
Net Income
-69.68-82.44-91.17-125.6-67.25
Upgrade
Net Income to Common
-69.68-82.44-91.17-125.6-67.25
Upgrade
Shares Outstanding (Basic)
5544363633
Upgrade
Shares Outstanding (Diluted)
5544363633
Upgrade
Shares Change (YoY)
25.19%21.00%0.38%9.97%1485.31%
Upgrade
EPS (Basic)
-1.27-1.88-2.51-3.47-2.04
Upgrade
EPS (Diluted)
-1.27-1.88-2.51-3.47-2.05
Upgrade
Free Cash Flow
-62.3-66.75-85.27-102.86-52.29
Upgrade
Free Cash Flow Per Share
-1.13-1.52-2.35-2.84-1.59
Upgrade
EBITDA
-75.49-86.02-92.32-126.67-69.52
Upgrade
D&A For EBITDA
0.340.440.510.210.05
Upgrade
EBIT
-75.84-86.46-92.83-126.87-69.57
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q